IDEAL PHARMA PEPTIDE together with Wuxi Jinghai Amino Acid will present new innovative peptide complexes at the exhibition CPhI Worldwide 2017
From 24 to 26 October 2017 in Frankfurt am Main (Germany) take place one of the most significant events in the field of pharmaceuticals - the world exhibition CPhI Worldwide 2017.
IDEAL PHARMA PEPTIDE GmbH will present own innovative products - amino acid peptide complexes IPH developed in cooperation with Wuxi Jinghai Amino Acid Co Ltd. Stand No 10.1F50
The decision of cooperation between IDEAL PHARMA PEPTIDE (Germany) and the company Wuxi Jinghai Amino Acid (China) was not incidentally. WJAA today is one of the leading manufacturers of amino acids in China with the right to export and import core products and raw materials and was established in 1993. Company is certified according to: GMP, HALAL, KOSHER, ISO 9001 and ISO 22000.
Wuxi Jinghai Amino Acid Co Ltd (WJAA, http://www.chinaaminoacid.com/) is one of the key players in China’s national development plan and one of the high-tech enterprises of Jiangsu Province, where it is located. In addition, WJAA is a member of China Pharmaceutical Industry Association.
The company has about 250 employes now. From total company area of 38,388 m² – production facilities occupy 16,762 m². The annual output is about 3000mts of amino acids. The production of WJAA is a complex of advanced producing technology and facilities, plus highly qualified personnel. The main brand of amino acids, which produces the company is AMINOWILL.
These factors played a key role in the decision to collaborate with WJAA as a producer of IPH peptide complexes such as BCAA IPH AGAA, BCAA IPH AVN and BCAA IPH AEN – products, created on technologies and short peptides of IDEAL PHARMA PEPTIDE GmbH (GERMANY), http://ideal-pharma.de/ and based on high-quality amino acids of AMINOWILL. End users of these products are European and American companies specializing in innovative solutions in production of sports nutrition.